Reaction
Epididymitis reporting signals
As of the last recalculation, Epididymitis appears in 1,155 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is FINASTERIDE (PRR 23.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Finasteride | 74 | 23.5 | 23.6 |
| Polatuzumab Vedotin | 11 | 20.5 | 20.5 |
| Dextrose | 13 | 18.0 | 18.0 |
| Dextrose Monohydrate | 13 | 17.7 | 17.7 |
| Thiotepa | 9 | 17.1 | 17.1 |
| Ivacaftor | 7 | 16.0 | 16.0 |
| Ganciclovir | 9 | 16.0 | 16.0 |
| Basiliximab | 10 | 15.4 | 15.5 |
| Busulfan | 12 | 13.9 | 13.9 |
| Dapagliflozin | 22 | 12.8 | 12.8 |
| Minocycline | 8 | 12.4 | 12.5 |
| Obinutuzumab | 11 | 12.2 | 12.2 |
| Filgrastim | 24 | 11.7 | 11.7 |
| Testosterone Cypionate | 5 | 10.1 | 10.1 |
| Dornase Alfa | 5 | 4.6 | 4.6 |
| Pirfenidone | 10 | 4.5 | 4.5 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 4.3 | 4.3 |
| Bimekizumab | 5 | 4.2 | 4.2 |
| Minoxidil Foam 5% (Womens) | 5 | 2.7 | 2.7 |